ABRAXIS
Live / Registered — Registered and renewed (as of 18 Jan 2016)
What this means for you
Registered since 04 Apr 2006. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 04 Apr 2016).
Record
- Serial number
- 78334600
- Registration number
- 3077449
- Mark type
- Stylized text
- Filed
- 01 Dec 2003
- Published for opposition
- 05 Jul 2005
- Registered
- 04 Apr 2006
- Next maintenance due
- 04 Apr 2016
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of cancer
- Class 042 — Scientific and technological services: research and development in the field of pharmaceuticals for the treatment of cancer and consultation therewith
Owner
- ABRAXIS BIOSCIENCE, LLC, Summit, NJ, US
- CELGENE CORPORATION, SUMMIT, NJ, US
- ABRAXIS BIOSCIENCE, LLC, LOS ANGELES, CA, US
- American Pharmaceutical Partners, Inc., Schaumburg, IL, US
- American Pharmaceutical Partners, Inc., Schaumburg, IL, US
- American Pharmaceutical Partners, Inc., Schaumburg, IL, US
Prosecution history
- 04 Apr 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 09 Dec 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 09 Dec 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Dec 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 09 Dec 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 Dec 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Dec 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 03 May 2017 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 18 Jan 2016 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 18 Jan 2016 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 18 Jan 2016 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 18 Jan 2016 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 04 Nov 2015 — TEAS SECTION 8 & 9 RECEIVED
- 27 Jun 2012 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 21 Apr 2011 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.